Accept Refuse

EUR-Lex Access to European Union law

This document is an excerpt from the EUR-Lex website

Document 62014CN0592

Case C-592/14: Reference for a preliminary ruling from the High Court of Justice (England and Wales), Queen's Bench Division (Administrative Court) (United Kingdom) made on 19 December 2014 — European Federation for Cosmetic Ingredients v Secretary of State for Business, Innovation and Skills

OJ C 81, 9.3.2015, p. 8–9 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

9.3.2015   

EN

Official Journal of the European Union

C 81/8


Reference for a preliminary ruling from the High Court of Justice (England and Wales), Queen's Bench Division (Administrative Court) (United Kingdom) made on 19 December 2014 — European Federation for Cosmetic Ingredients v Secretary of State for Business, Innovation and Skills

(Case C-592/14)

(2015/C 081/10)

Language of the case: English

Referring court

High Court of Justice (England and Wales), Queen's Bench Division (Administrative Court)

Parties to the main proceedings

Applicant: European Federation for Cosmetic Ingredients

Defendants: Secretary of State for Business, Innovation and Skills, Attorney General

Interveners: British Union for the Abolition of Vivisection, European Coalition to End Animal Experiments

Questions referred

1.

Is Article 18(l)(b) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (1) to be interpreted as prohibiting the placing on the Community market of cosmetic products containing ingredients, or a combination of ingredients, which have been the subject of animal testing where that testing was performed outside the European Union to meet the legislative or regulatory requirements of third countries in order to market cosmetic products containing those ingredients in those countries?

2.

Does the answer to question (1) depend on: -

(a)

whether the safety assessment carried out in accordance with Article 10 of that Regulation to demonstrate that the cosmetic product is safe for human health prior to it being made available on the Community market would involve the use of data resulting from the animal testing performed outside the European Union;

(b)

whether the legislative or regulatory requirements of the third countries for which the animal testing was undertaken relate to the safety of cosmetic products;

(c)

whether it was reasonably foreseeable, at the time that an ingredient was subjected to animal testing outside the European Union, that any person might seek to place a cosmetic product including that ingredient at some stage on the Community market; and/or

(d)

any other factor, and if so, what factor?


(1)  OJ L 342, p. 59


Top